Healthcare - Sector
Evofem Biosciences's activity chart (see below) currently has 52 price targets and 36 ratings on display.
Analysts' price targets on this stock were met 4.91% of the time, taking 21.25 days on average.
Most recent stock forecast was given by ANNABEL SAMIMY from STIFEL on 12-Oct-2022. First documented stock forecast 14-Dec-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Oct-2020
$2.5
$6000
4 years 1 months 9 days ago
(12-Oct-2022)
1/4 (25%)
$-9.63 (-79.39%)
149
Buy Since 19-Mar-2018
$3750
4 years 3 months 6 days ago
(15-Aug-2022)
0/9 (0%)
$2698.12 (256.50%)
Sell Since 15-Nov-2021
$250
4 years 4 months 6 days ago
(15-Jul-2022)
1/7 (14.29%)
$116.25 (86.92%)
21
Buy Since 08-Jun-2020
$250
$3750
4 years 5 months 27 days ago
(25-May-2022)
0/4 (0%)
$205 (455.56%)
Buy Since 18-Jun-2018
$33750
$46874.98
6 years 3 months 11 days ago
(10-Aug-2020)
0/5 (0%)
$28031.25 (490.16%)
What is EVFM (Evofem Biosciences) average time for price targets to be met?
Which analyst most recently updated their price target on EVFM (Evofem Biosciences)?
Which analyst has the lowest performance score on EVFM (Evofem Biosciences) with a proven track record?
Which analyst has the most public recommendations on EVFM (Evofem Biosciences)?
Which analyst is the currently most bullish on EVFM (Evofem Biosciences)?
Which analyst is the currently most reserved on EVFM (Evofem Biosciences)?